Eli Lilly and Company LLY NYSE

NYSE • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score

86/100

5/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Eli Lilly and Company (LLY), dont 26 achats et 20 ventes. Le total des achats d'initiés s'élève à $101.19M et le total des ventes d'initiés à $11.32M.

Les initiés notables ayant une activité récente comprennent Brown Adrienne S, Custer Kenneth L., Brooks Gordon J.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — LLY

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2028-02-16	Brown Adrienne S	EVP, President Lly Imm	Inconnu	354	-	-	-
2028-02-16	Custer Kenneth L.	EVP & President, Card Met Hlth	Inconnu	177	-	-	-
2027-02-16	Brooks Gordon J.	Interim CFO, Group VP	Cession	278	-	-	-
2026-11-01	Dozier Eric	EVP, HR & Diversity	Cession	2,300	-	-	-
2026-11-01	Montarce Lucas	EVP & CFO	Cession	1,610	-	-	-
2026-03-16	Sulzberger Gabrielle	Director	Attribution de RSU	5	$989.12	$4.95K	2,976
2026-03-16	Alvarez Ralph	Director	Attribution de RSU	13	$989.12	$12.86K	55,601
2026-03-16	Fyrwald J Erik	Director	Attribution de RSU	10	$989.12	$9.89K	75,259
2026-03-16	Luciano Juan R	Director	Attribution de RSU	16	$989.12	$15.83K	16,817
2026-02-19	Dozier Eric	EVP, Chief People Officer	Don (Donné)	481	-	-	14,455
2026-02-17	Sulzberger Gabrielle	Director	Attribution de RSU	5	$1,036.05	$5.18K	2,966
2026-02-17	Alvarez Ralph	Director	Attribution de RSU	12	$1,036.05	$12.43K	55,492
2026-02-17	Fyrwald J Erik	Director	Attribution de RSU	10	$1,036.05	$10.36K	75,120
2026-02-17	Luciano Juan R	Director	Attribution de RSU	15	$1,036.05	$15.54K	16,772
2026-02-16	Zakrowski Donald A	SVP, Finance, & CAO	Exercice d'Options (Vente)	184	-	-	-
2026-02-16	Montarce Lucas	EVP & CFO	Exercice d'Options (Vente)	368	-	-	-
2026-02-16	Custer Kenneth L.	EVP & President, Card Met Hlth	Exercice d'Options (Vente)	207	-	-	-
2026-02-16	Brown Adrienne S	EVP, President Lly Imm	Exercice d'Options (Vente)	391	-	-	-
2026-02-09	Ricks David A	President, Chair, and CEO	Attribution de RSU	38,914	$1,044.67	$40.65M	571,715
2026-02-09	Zakrowski Donald A	SVP, Finance, & CAO	Attribution de RSU	199	-	-	199
2026-02-09	Van Naarden Jacob	EVP,pres Lly Oncology&hdcorpbd	Attribution de RSU	4,866	$1,044.67	$5.08M	26,626
2026-02-09	Hakim Anat	EVP, Gc & Secretary	Attribution de RSU	8,278	$1,044.67	$8.65M	22,987
2026-02-09	Skovronsky Daniel	EVP, Cs&po & Pres. Lrl	Attribution de RSU	15,548	$1,044.67	$16.24M	160,072
2026-02-09	Montarce Lucas	EVP & CFO	Attribution de RSU	1,365	$1,044.67	$1.43M	16,050
2026-02-09	Jonsson Patrik	EVP & President, Lly Int'l	Attribution de RSU	4,818	$1,044.67	$5.03M	60,647
2026-02-09	Yuffa Ilya	EVP&pres, Lly Usa&global Capab	Attribution de RSU	4,163	$1,044.67	$4.35M	32,304
2026-02-09	Rau Diogo	EVP & Cido	Attribution de RSU	4,432	$1,044.67	$4.63M	26,230
2026-02-09	Hernandez Edgardo	EVP & Pres., Mfg. Operations	Attribution de RSU	4,384	$1,044.67	$4.58M	46,096
2026-02-09	Dozier Eric	EVP, Chief People Officer	Attribution de RSU	3,512	$1,044.67	$3.67M	14,936
2026-02-09	Custer Kenneth L.	EVP & President, Card Met Hlth	Attribution de RSU	659	$1,044.67	$688.44K	10,025
2026-02-09	Brown Adrienne S	EVP, President Lly Imm	Attribution de RSU	1,196	$1,044.67	$1.25M	4,921
2026-02-09	Rau Diogo	EVP & Cido	Attribution de RSU	4,599	$1,044.67	$4.8M	26,397
2026-02-01	Ricks David A	President, Chair, and CEO	Exercice d'Options (Vente)	31,932	-	-	-
2026-02-01	Van Naarden Jacob	EVP,pres Lly Oncology&hdcorpbd	Exercice d'Options (Vente)	4,108	-	-	-
2026-02-01	Hakim Anat	EVP, Gc & Secretary	Exercice d'Options (Vente)	6,700	-	-	-
2026-02-01	Skovronsky Daniel	EVP, Cs&po & Pres. Lrl	Exercice d'Options (Vente)	12,684	-	-	-
2026-02-01	Jonsson Patrik	EVP & President, Lly Int'l	Exercice d'Options (Vente)	3,930	-	-	-
2026-02-01	Yuffa Ilya	EVP&pres, Lly Usa&global Capab	Exercice d'Options (Vente)	3,394	-	-	-
2026-02-01	Rau Diogo	EVP & Cido	Exercice d'Options (Vente)	3,752	-	-	-
2026-02-01	Hernandez Edgardo	EVP & Pres., Mfg. Operations	Exercice d'Options (Vente)	3,572	-	-	-
2026-02-01	Dozier Eric	EVP, Chief People Officer	Exercice d'Options (Vente)	2,858	-	-	-
2026-01-20	Sulzberger Gabrielle	Director	Attribution de RSU	5	$1,041.29	$5.21K	2,961
2026-01-20	Alvarez Ralph	Director	Attribution de RSU	12	$1,041.29	$12.5K	55,480
2026-01-20	Fyrwald J Erik	Director	Attribution de RSU	10	$1,041.29	$10.41K	75,111
2026-01-20	Luciano Juan R	Director	Attribution de RSU	15	$1,041.29	$15.62K	16,757
2026-01-07	Lilly Endowment Inc	10 Percent Owner	Vente Informative	2,737	$1,116.69	$3.06M	91,896,978
2026-01-05	Lilly Endowment Inc	10 Percent Owner	Vente Informative	1,390	$1,085.01	$1.51M	92,189,126
2025-12-31	Ho Carole	EVP & Pres, Lilly Neuroscience	Inconnu	2,741	-	-	-
2025-12-29	Lilly Endowment Inc	10 Percent Owner	Vente Informative	3,593	$1,085.04	$3.9M	92,190,516
2025-12-24	Lilly Endowment Inc	10 Percent Owner	Vente Informative	2,629	$1,085.17	$2.85M	92,194,109

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration